Department of Bioengineering and Therapeutic Sciences

QBI and Director Krogan’s COVID and infectious disease efforts continue to make waves

QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.

Update from the Dean: Putting plans in action

Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.

The Kidney Project proves its bioreactor can keep kidney cells alive for at least one week

Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.

A budding partnership with Korean regulatory science pharmacists

A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

Innovation gets a boost from 2023 Koda-Kimble Seed Awards

This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.

Faculty Resource Fair and Development Day 2023

All faculty are invited to the following networking and development events.

Willow Coyote-Maestas, PhD, MS

Assistant Professor

Rebecca Shubin

Academic Program Coordinator

Having worked in higher education at UC Berkeley, Stanford University, and UCSF, I enjoy supporting students, faculty, and programs where I value equity, teamwork, and community to assist people in changing the world through engineering, curiosity, and innovation. During my time not at work, you...

Fraser named chair of UCSF Department of Bioengineering and Therapeutic Sciences

James Fraser, PhD, plans to build on department strengths in computational biology and promote open science.

Regulatory science at UCSF gets major boost with FDA CERSI renewal

The FDA announces the Centers of Excellence in Regulatory Science and Innovation (CERSI) renewals, granting up to $50M for UCSF’s joint effort with Stanford.